NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: MEDANTA · data 2026-10-30
Global Health Limited
In plain words
Price: 17.7% below its 52-week high of ₹1,544.
Delivery: 59.4% of traded shares were kept for delivery over the last 10 sessions, against 55.1% over the last 60.
Latest results: a net profit of ₹143 cr for the quarter ended Dec 2024 (+15.6% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹4,683 cr |
| Net profit (last 12 months) | ₹556 cr |
| Sales growth, 3 years (yearly) | 17.2% |
| Profit growth, 3 years (yearly) | 19.5% |
Smart-money activity
20/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 8/30: Delivery 59.9% over the last 20 sessions vs 53.9% in the 40 before (1.11x); shares delivered per day 0.84x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 4 schemes hold it, about ₹119 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results
- 14 Aug 26Dividend Dividend ₹0.5 (ex-date) +0.3% next session
- 4 Feb 25Results Q3 FY25 results: profit +15.6% YoY +10.6% next session
- 14 Nov 24Results Q2 FY25 results: profit +4.5% YoY +4.7% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Dec 2024 | ₹943 cr | ₹143 cr | +15.6% | 25.2% | 5.32 |
| Sept 2024 | ₹957 cr | ₹131 cr | +4.5% | 23.9% | 4.87 |
| Jun 2024 | ₹861 cr | ₹106 cr | +4.2% | 21.6% | 3.96 |
| Mar 2024 | ₹809 cr | ₹127 cr | +26.0% | 22.2% | 4.74 |
Common questions
What was Global Health Limited's latest quarterly profit?
Global Health Limited reported a net profit of ₹143 cr for the quarter ended Dec 2024 (+15.6% on the same quarter a year earlier), on revenue of ₹943 cr.
Is Global Health Limited debt-free?
Its latest reported debt-to-equity ratio is 0.3.
What is Global Health Limited's P/E ratio?
About 61.4, based on the last 12 months' earnings and a price of ₹1,270.3 (data 2026-10-30).
What is the 52-week high and low of Global Health Limited?
The 52-week high is ₹1,544 and the 52-week low is ₹956.
Mutual funds holding Global Health Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 4 schemes holding about ₹119 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| SBI Healthcare Opportunities Fund | SBI Mutual Fund | 1.74% | ₹102 cr |
| Nippon India Active Momentum Fund | Nippon India Mutual Fund | 2.36% | ₹14 cr |
| Nippon India Consumption Fund | Nippon India Mutual Fund | 0.13% | ₹3 cr |
| Mirae Asset Nifty 500 Healthcare ETF | Mirae Asset Mutual Fund | 0.90% | ₹0 cr |
Similar companies
Max Healthcare Institute Ltd (MAXHEALTH) · Aster DM Quality Care Limited (ASTERDM) · Fortis Healthcare Ltd. (FORTIS) · Narayana Hrudayalaya Ltd. (NH) · Krishna Institute of Medical Sciences Limited (KIMS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MEDANTA in NSE Scanner →